Atlas Trials

Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

Clinical trial NCT04806737 · COMPLETED

Trial details

NCT number
NCT04806737
Sponsor
Oslo University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2021-04-16
Primary completion
2022-10-15
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.